Why BGPT?
logo

Biochemistry — Molecular Data Access

Retrieve assays, kinetics, and structural data extracted from full-text biochemical studies.

Press Enter ↵ to search



    Explore by Goal




     Quick Explanation



    EF‑P polyproline stalling: what the raw assays + structures support
    EF‑P rescues ribosomes stalled by polyproline runs by stabilizing/positioning the P‑site tRNA and promoting peptide bond formation, which is consistent with cryo‑EM of polyproline‑stalled ribosomes ± EF‑P.
    Sequence context matters: EF‑P’s modification state (β‑lysylation vs rhamnosylation) depends strongly on its β3β4 loop composition, including the near-essential proline at the −2 position (P32) for lysine-type EF‑P function; these modification shifts correlate with ribosome rescue outcomes in bacterial reporters and rhamnosylation assays.



     Long Explanation



    EF‑P polyproline ribosome stall (consecutive proline codons) — raw-translation-assay evidence map
    You asked for: "EF‑P polyproline ribosome stall consecutive proline codons raw translation assays". Below is a skeptical, evidence-grounded synthesis of what the provided research data supports: (i) EF‑P structural mechanism in polyproline stalls, (ii) how EF‑P sequence/modification state controls rescue, and (iii) how polyproline stalling shows up as functional translation defects.
    Figure 1 — Polyproline stalling is mechanistically rescued by EF‑P (structural evidence)
    Cryo‑EM supports the mechanistic model: polyproline stalls correlate with P‑site tRNA destabilization, and EF‑P resolves the stalled state by stabilizing the P‑site tRNA and enabling peptide bond formation.
    Figure 2 — EF‑P-enhancement magnitude for polyproline translation (range reported)
    The provided dataset summary indicates EF‑P boosts proline-containing products strongly in polyproline contexts (order-of-magnitude range). Because the excerpt reports a range (10–100×) rather than per-condition raw points, the plot shows the stated bounds only (no fabricated intermediate datapoints).
    Figure 3 — EF‑P β3β4 loop governs modification type (lysylation vs rhamnosylation)
    In the bacterial EF‑P sequence dataset excerpt, the β3β4 composition is summarized as a frequency distribution across EF‑P variants (lysine-type vs arginine-type at the key position). This matters because the downstream translation rescue depends on which modification pathway EF‑P can take.
    Figure 4 — The −2 proline (P32) dependency links EF‑P modification chemistry to ribosome rescue
    The excerpt emphasizes that Pro at P32 is nearly essential for lysylated EF‑P function and is largely incompatible with rhamnosylated EF‑P in the same context; loop mutations and swaps modulate modification efficiency and rescue phenotypes.
    Figure 5 — Polyproline stalling is a recurring theme beyond bacterial EF‑P (mitochondrial context)
    To avoid overgeneralizing from bacteria: a human mitochondrial translation-factor study shows polyproline-associated mitoribosome stalls (e.g., PPP motifs) correlate with reduced production of specific mitochondrial proteins when the factor is knocked out. This supports the idea that polyproline stalls are a general translation problem, but does not prove EF‑P equivalence across organelles.
    Evidence chain (known vs uncertain)
    Known / strongly supported by the provided sources
    • Polyproline stretches stall ribosomes and EF‑P can structurally rescue those stalled states by stabilizing the P‑site tRNA and promoting peptide bond formation.
    • EF‑P modification pathway choice depends on its β3β4 loop (lysine-type vs arginine-type signature), with functional rescue strongly coupled to compatible sequence features such as P32.
    Uncertain / depends on context (potential blind spots)
    • “Raw translation assay” quantitative details are incomplete in the provided excerpt. The EF‑P fold-change is reported as a range (10–100×) rather than per-proline-run raw points, so Figure 2 shows only the stated bounds.
    • Cross-species generalization is not guaranteed. Bacterial EF‑P modification machinery and mitochondrial stall-management factors are mechanistically analogous at a high level (polyproline stalls), but they are not necessarily the same proteins or pathways.
    • In vitro translation systems can diverge from cellular translation. The ribosome-engineering assay excerpt is explicitly in purified/in vitro translation; such systems can illuminate mechanisms yet may not reproduce native regulation/stoichiometry.


    Feedback:   

    Updated: July 07, 2026

     Top Data Sources ExportMCP



     Analysis Wizard



    You will extract EF‑P variant sequence features (β3β4 K34/R34; P32 presence) from the provided EF‑P dataset summary, then map them to reported lysylation/rhamnosylation and rescue categories, producing a feature→phenotype heatmap.



     Hypothesis Graveyard



    A simple hypothesis that “EF‑P presence alone determines rescue magnitude” is less supported by the provided EF‑P modification switching evidence, because rescue is coupled to β3β4/P32 compatibility and modification pathway choice.

     Science Art


    EF-P polyproline ribosome stall consecutive proline codons raw translation assays Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Follow the Evidence

    New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.


    My BGPT